Patents by Inventor Ernest DODOO

Ernest DODOO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION AND SELECTION OF TUMOR UBER REACTIVE IMMUNE CELLS (TURICS)
    Publication number: 20210214686
    Abstract: The present invention relates to a method for producing a T-cell product containing tumor uber reactive immune cells (TURICs) and a composition containing at least one T-cell product with TURICs for use in treatment of a cancer patient.
    Type: Application
    Filed: July 31, 2019
    Publication date: July 15, 2021
    Applicant: POLYBIOCEPT GMBH
    Inventors: Ernest DODOO, Markus MAEURER
  • METHOD FOR THE TREATMENT OF A TUMOR PATIENT WITH ADOPTIVE T CELL IMMUNOTHERAPY
    Publication number: 20210169937
    Abstract: The present invention relates to a method of treating a tumor disease, comprising one or more administrations of a T cell product, a T cell product for use in a method of treating a tumor disease, as well as a kit for use in a method of treating a tumor disease.
    Type: Application
    Filed: July 26, 2019
    Publication date: June 10, 2021
    Applicant: NORDWEST POLYBIOCEPT BIOSCIENCE GMBH
    Inventors: Ernest DODOO, Elke JÄGER, Julia KARBACH, Markus MAURER
  • Culture medium for cellular immunotherapy
    Patent number: 10975353
    Abstract: The present invention provides a method for preparing a cell culture medium comprising a mixture of blood products from two or more donors, comprising the steps of: a) providing at least a first blood product from a first donor; b) measuring the concentration of at least one quality factor in the first blood product; c) comparing the measured concentration of a quality factor to a concentration range predefined for the quality factor; d) selecting the first blood product for the cell culture medium if the concentration measured for the quality factor is in the predefined range and optionally converting the first selected blood product into a first processed blood product or else unselecting the first blood product.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: April 13, 2021
    Assignee: polybiocept GmbH
    Inventors: Jakob Geyer, Markus Maeurer, Ernest Dodoo
  • T-CELL RECEPTOR SEQUENCES FOR ACTIVE IMMUNOTHERAPY
    Publication number: 20200368277
    Abstract: The present invention provides a protein, in particular a TCR comprising a V? amino acid sequence with a sequence identity of at 90%, to a sequence selected from SEQ ID NO: 1 to 27, a T-cell comprising the TCR a method of selecting a T-cell product for use in active immunotherapy based on the identification of an V? amino acid sequence with a sequence identity of at 90%, to a sequence selected from SEQ ID NO: 1 to 27 in a T-cell product.
    Type: Application
    Filed: February 8, 2017
    Publication date: November 26, 2020
    Applicant: POLYBIOCEPT GMBH
    Inventors: Markus MAEURER, Ernest DODOO
  • CULTURE MEDIUM FOR CELLULAR IMMUNOTHERAPY
    Publication number: 20170121680
    Abstract: The present invention provides a method for preparing a cell culture medium comprising a mixture of blood products from two or more donors, comprising the steps of: a) providing at least a first blood product from a first donor; b) measuring the concentration of at least one quality factor in the first blood product; c) comparing the measured concentration of a quality factor to a concentration range predefined for the quality factor; d) selecting the first blood product for the cell culture medium if the concentration measured for the quality factor is in the predefined range and optionally converting the first selected blood product into a first processed blood product or else unselecting the first blood product.
    Type: Application
    Filed: June 10, 2015
    Publication date: May 4, 2017
    Applicant: POLYBIOCEPT AB
    Inventors: Jakob GEYER, Markus MAEURER, Ernest DODOO